Isomorphic’s $5 Billion Raise Is a Bet, Not a Medicine
AI-generated summary Isomorphic Labs announced a Series C fundraising round of $5 billion to design new medicines with artificial intelligence. Greenoaks and Sequoia Capital co-led the oversubscribed round, with participation from Alphabet, Andreessen Horowitz, and other backers.